Insight Molecular Diagnostics Inc.
IMDX- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001642380
No open-market purchases or sales by Insight Molecular Diagnostics Inc. insiders were filed in the last 90 days; 40 institutions reported holding it in 13F filings for Q2 2026, worth $108.9M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Insight Molecular Diagnostics Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- 0 vs. Q4 2023
- Shares held
- 4.37M
- −80.8K (−1.8%) vs. Q4 2023
- Total value
- $12.8M
- +$1.69M (+15.3%) vs. Q4 2023
- New holders
- 2
- 3 more added
- Sold out
- 2
- 8 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 40 | $108.9M |
| Q1 2026 | 41 | $62.1M |
| Q4 2025 | 35 | $124.9M |
| Q3 2025 | 27 | $54.1M |
| Q2 2025 | 30 | $48.9M |
| Q1 2025 | 30 | $49.2M |
| Q4 2024 | 27 | $20.0M |
| Q3 2024 | 21 | $20.4M |
| Q2 2024 | 23 | $21.1M |
| Q1 2024 | 25 | $12.8M |
| Q4 2023 | 26 | $11.1M |
| Q3 2023 | 30 | $14.3M |
| Q2 2023 | 47 | $21.1M |
| Q1 2023 | 52 | $19.7M |
| Q4 2022 | 59 | $19.5M |
| Q3 2022 | 65 | $48.3M |
| Q2 2022 | 76 | $61.8M |
| Q1 2022 | 86 | $81.1M |
| Q4 2021 | 89 | $120.1M |
| Q3 2021 | 95 | $201.9M |
| Q2 2021 | 91 | $324.6M |
| Q1 2021 | 87 | $283.0M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Insight Molecular Diagnostics Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 80 | $0 | 0.00% | −821−91.1% | Reduced |
| Qube Research & Technologies Ltd | 1 | $3 | 0.00% | 00.0% | Unchanged |
| Albion Financial Group | 7 | $21 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 13 | $38 | 0.00% | +13 | New |
| Comerica Bank | 23 | $67 | 0.00% | −1−4.2% | Reduced |
| Piscataqua Savings Bank | 25 | $73 | 0.00% | 00.0% | Unchanged |
| Riggs Asset Managment Co. Inc. | 50 | $147 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 61 | $179 | 0.00% | +1+1.7% | Added |
| Advisor Group Holdings, Inc. | 97 | $284 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 154 | $451 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 210 | $615 | 0.00% | −6−2.8% | Reduced |
| NBC Securities, Inc. | 150 | $1.00K | 0.00% | +150 | New |
| The PNC Financial Services Group, Inc. | 500 | $1.47K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 864 | $2.53K | 0.00% | −515−37.3% | Reduced |
| Tower Research Capital LLC (TRC) | 1,880 | $5.51K | 0.00% | −1,450−43.5% | Reduced |
| Renaissance Technologies LLC | 12,218 | $36.0K | 0.00% | −500−3.9% | Reduced |
| State Street Corp | 16,289 | $47.7K | 0.00% | 00.0% | Unchanged |
| Defender Capital, LLC. | 55,885 | $163.7K | 0.06% | −15,765−22.0% | Reduced |
| BlackRock Inc. | 60,187 | $176.3K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 62,433 | $183.0K | 0.00% | +951+1.5% | Added |
| Morgan Stanley | 123,211 | $361.0K | 0.00% | +238+0.2% | Added |
| Vanguard Group Inc | 247,873 | $726.3K | 0.00% | 00.0% | Unchanged |
| Pura Vida Investments, LLC | 523,928 | $1.54M | 1.04% | −63,002−10.7% | Reduced |
| AWM Investment Company, Inc. | 754,286 | $2.21M | 0.29% | 00.0% | Unchanged |
| Broadwood Capital Inc | 2,509,066 | $7.35M | 0.55% | 00.0% | Unchanged |
| Rhumbline Advisers | 0 | $0 | 0.00% | −66−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Coppell Advisory Solutions LLC | – | – | – | – | Not filed |